FURTHER SUBSIDISING SHINGRIX VACCINE FOR VULNERABLE YOUNGER SENIORS WITH CHRONIC CONDITIONS

NOTICE PAPER NO. 1349

NOTICE OF QUESTION FOR WRITTEN ANSWER  

FOR THE SITTING OF PARLIAMENT ON 6 OCTOBER 2026

Name and Constituency of Member of Parliament

Mr Alex Yeo

MP for Potong Pasir

Question No. 2094

To ask the Coordinating Minister for Social Policies and Minister for Health in view of the debilitating nature of shingles particularly for vulnerable seniors with other chronic medical conditions, whether the Ministry will consider further subsidising the estimated co-payment cost of $300 for the shingrix vaccine over two-doses, for younger seniors who are not of the Pioneer or Merdeka Generation.

Answer

1                The cost of the Shingrix vaccine is highly subsidised – up to 75% for non-Pioneer or Merdeka Generation individuals, based on means-testing.  In addition, eligible individuals, including all aged 60 and above, can use MediSave to pay for the remaining cost after subsidies – up to $500 or $700 under MediSave500/700, and for those aged 60 years or older, an additional $400 under Flexi-MediSave. After subsidies and MediSave, they may have zero out-of-pocket costs for the vaccination.

2                MOH will continue to ensure that recommended vaccinations remain affordable to patients through relevant subsidies and MediSave use.